![Thomas Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Lynch
Compliance Officer bij
BILLIONTOONE, INC.
Vermogen: 63 469 $ op 31-08-2026
Profiel
Thomas P.
Lynch is currently Secretary & Chief Compliance Officer at BillionToOne, Inc. since 2022.
Formerly, served as Secretary, Chief Legal & Compliance Officer at Nuwellis, Inc. from 2018 to 2021; Secretary, Chief Administrative Officer & EVP at Orexigen Therapeutics, Inc. from 2017 to 2018; Senior Legal Counsel at Novartis Corp.
from 2012 to 2015; and Head-Legal & Compliance at Novartis Pharma AG.
Education includes undergraduate studies at Stanford University, graduate degrees from the University of St. Thomas, and Boston College Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-09-2026 | 700 ( 0% ) | 63 469 $ | 31-08-2026 |
Actieve functies van Thomas Lynch
| Bedrijven | Functie | Begin |
|---|---|---|
| BILLIONTOONE, INC. | Compliance Officer | - |
Eerdere bekende functies van Thomas Lynch
| Bedrijven | Functie | Einde |
|---|---|---|
| NUWELLIS, INC. | Compliance Officer | 07-06-2021 |
| OREXIGEN THERAPEUTICS, INC. | President | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Algemeen Adviseur | 01-11-2015 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Compliance Officer | - |
Opleiding van Thomas Lynch
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Nuwellis, Inc.
 Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Thomas
 University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BillionToOne, Inc.
 BillionToOne, Inc. Medical/Nursing ServicesHealth Services Operates as a precision diagnostics company that quantifies biology to create molecular diagnostics | Health Services |
